Patents Assigned to Develogen Aktiengesellschaft fur Entwicklungsbiologische Forshung
  • Patent number: 7404952
    Abstract: The present invention discloses three novel proteins regulating the energy homeostasis and the metabolism of triglycerides, and polynucleotides, which identify and encode the proteins disclosed in this invention. The invention also relates to vectors, host cells, antibodies, and recombinant methods for producing the polypeptides and polynucleotides of the invention. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight regulation, for example, but not limited to, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, wasting syndromes (cachexia), pancreatic dysfunctions (such as diabetes mellitus), hypertension, pancreatic dysfunctions, arteriosclerosis, coronary artery disease (CAD), coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstones, cancer, e.g. cancers of the reproductive organs, sleep apnea, and others.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: July 29, 2008
    Assignee: Develogen Aktiengesellschaft fur Entwicklungsbiologische Forshung
    Inventors: Karsten Eulenberg, Gunter Bronner, Thomas Ciossek, Thomas Hader, Arnd Steuernagel